Shares double to S$0.002: Clearbridge Health 1H3.SI (SES) after-hours move

Clearbridge Health Limited (1H3.SI) rallied to S$0.002 in after-hours trading on 19 Feb 2026 after an intraday push from S$0.001. The move showed a 100.00% change and traded 498,900 shares today on the Singapore Exchange (SES). We flag 1H3.SI stock as a high-volume mover because the jump followed fresh trading flows ahead of an earnings announcement scheduled for 27 Feb 2026. This note summarises price action, financial metrics, technicals, and our model-driven outlook.

1H3.SI stock intraday move and volume

Today Clearbridge Health (1H3.SI) traded between S$0.001 and S$0.002, closing the session at S$0.002 in after-hours. Volume reached 498,900 versus an average daily volume of 6,609,328, which indicates a notable intraday pickup even if below the long-term average. The immediate driver appears to be pre-earnings positioning ahead of the 27 Feb 2026 earnings release and a short-term technical rebound from the year low of S$0.001.

Trading context, catalysts and sector view

Clearbridge Health operates in Healthcare on the SES and the business spans imaging, clinics and strategic investments across Singapore and Southeast Asia. Sector peers show modest 1Y gains and average valuations higher than Clearbridge’s, leaving 1H3.SI priced at a deep discount on book metrics. A near-term catalyst is the upcoming earnings report on 27 Feb 2026; another is any update to clinic operations or strategic investments that could alter cash flow visibility. For reference, the broader Healthcare sector in Singapore has a one-year performance near +17.81%, which provides a mix of tailwinds and competition for capital.

Valuation and key financial metrics for 1H3.SI stock

Clearbridge shows a market capitalisation of S$4,295,821.00 and 4,295,820,825 shares outstanding. Price-to-book is low at 0.13, price-to-sales is 0.58, and trailing PE is not meaningful due to negative earnings per share. The company reports book value per share of S$0.00850 and cash per share of S$0.00060. Current ratio is 1.73 and debt-to-equity is 0.12, suggesting limited leverage but negative profitability with net income per share of -S$0.00130.

Technical snapshot and short-term signals

Technical indicators show 1H3.SI stock in oversold territory with RSI 37.56 and CCI -187.63, while ADX at 76.77 signals a strong trending move. The 50-day average price is S$0.00188 and the 200-day average is S$0.00261, placing the current price slightly above the 50-day mean and below the 200-day mean. Momentum indicators and on-balance volume show recent selling pressure followed by a short-term recovery, implying a volatile trading range.

Meyka AI rates and model forecasts for 1H3.SI stock

Meyka AI rates 1H3.SI with a score of 61.53 out of 100 (Grade B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12-month price of S$0.00743, a 3-year price of S$0.01857, and a 5-year price of S$0.02968. These model outputs compare to the current price S$0.002 and imply a 12-month upside of 271.66% and a 3-year upside of 828.69%, respectively. Forecasts are model-based projections and not guarantees.

Price targets, risks and trading strategy

Analyst-style price targets tied to Meyka forecasts: short-term resistance at S$0.005 (recent year high S$0.005), 12-month target S$0.007 (model), and longer-term target S$0.018–S$0.030 conditional on margin recovery and strategic wins. Key risks include continued negative earnings, low free cash flow per share (-S$0.00076), thin liquidity relative to large-cap peers, and execution risk in the Healthcare Systems segment. Traders should size positions small, use tight stops, and consider the stock’s illiquidity on exits.

Final Thoughts

Clearbridge Health Limited (1H3.SI) registered an after-hours uptick to S$0.002 on 19 Feb 2026, trading 498,900 shares as traders positioned ahead of an earnings update on 27 Feb 2026. The company shows deep valuation discounts with PB 0.13 and P/S 0.58, but negative profitability and weak cash flow keep risk elevated. Meyka AI’s forecast model projects a 12-month price of S$0.00743, which implies a 271.66% upside from today’s price; longer horizon projections expand upside further, but these are model-driven and not guarantees. For high-volume mover strategies, 1H3.SI stock offers clear volatility and asymmetric reward scenarios, yet the combination of low liquidity, negative EPS, and operational execution risk argues for a cautious approach. Monitor earnings on 27 Feb 2026, trading volume spikes, and any management guidance that could change cash flow visibility. For more company details visit the Clearbridge site and the SES company page for filings and announcements.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.